FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1967252020> ?p ?o ?g. }

• W1967252020 endingPage "615" @default.
• W1967252020 startingPage "600" @default.
• W1967252020 abstract "Patients with immunoglobulin (Ig)A and/or IgG subclass deficiency may be asymptomatic or may have recurrent, mainly respiratory infections. This study compared the clinical efficacy and tolerability of prophylactic therapy with either the oral immunomodulator bacterial extract OM-85 BV or benzathine penicillin G (BPG) in the prevention of recurrent infections in symptomatic patients. In this 26-month, prospective, randomized study conducted at the Department of Pediatric Immunology, Ege University (Izmir, Turkey), children aged 1 to 12 years with recurrent infections and IgA and/or IgG subclass deficiency were enrolled. After an initial 12-month control period, patients were randomized to receive OM-85 BV or BPG. OM-85 BV (3.5-mg capsule) was given once daily for the first 10 days of each month for the first 3 months of the study. IM injections of BPG were given at a dose of 1.2 million units (for patients with body weight > 27 kg) or at a half-dose (for patients with body weight ≤27 kg) every 3 weeks for 12 months. In nonresponders (ie, those who continued to have recurrent infections at 12-month follow-up), IV immunoglobulin (IVIG) replacement therapy at 400 mg/kg body weight was given every 4 weeks for an additional 12 months. The results of IVIG therapy were assessed by the authors using clinical observation. Adverse effects and adverse drug reactions were documented by the authors for each vaccine, prophylactic therapy, and IVIG. A total of 91 children (56 boys, 35 girls; mean [SD] age at the start of the control period, 46.4 [31.0] months) were enrolled. Of these, 44 were randomized to the OM-85 BV group and 47 to the BPG group. The year before prophylactic therapy, the mean (SD) number of reported infections was 10.7 (3.6) and the mean (SD) number of antibiotic courses was 9.7 (3.6) (OM-85 BV group: mean [SD] number of reported infections, 10.5 [3.3]; mean (SD) number of antibiotic courses, 9.3 [3.3]; BPG group: mean [SD] number of reported infections, 10.8 [3.9], mean (SD) number of antibiotic courses, 10.1 [3.9]). At 12 months, the number of infections and antibiotic courses decreased significantly in the entire study population, but the between-group difference was not significant. Five patients in each group (OM-85 BV group, 11.4%; BPG group, 10.6%) were considered nonresponders and received IVIG treatment. Compared with responders, nonresponders were significantly younger (mean [SD] age, 34.40 [21.70] months vs 52.65 [30.52] months; P = 0.036) and had lower serum IgG (P<0.001), IgG1 (P = 0.006), IgG2 (P = 0.003), IgG3 (P = 0.035), and IgM (P = 0.008) levels and antibody responses to tetanus toxoid and Haemophilus influenzae type b (Hib) vaccines (P = 0.036 and 0.013, respectively). At 12-month follow-up, a protective effect of the prophylactic IVIG therapy was seen, with a statistically significant reduction in the number of infections to 3.3 (2.4) and in the number of antibiotic courses to 2.7 (2.5) (both P = 0.005). In this study population of children with recurrent infections and IgA and/or IgG subclass deficiency, prophylactic therapy with either OM-85 BV or an antibiotic significantly decreased the number of infections per year. In addition, nonresponders benefited from IVIG replacement therapy." @default.
• W1967252020 created "2016-06-24" @default.
• W1967252020 creator A5020939794 @default.
• W1967252020 creator A5037180436 @default.
• W1967252020 date "2003-09-01" @default.
• W1967252020 modified "2023-10-06" @default.
• W1967252020 title "Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency" @default.
• W1967252020 cites W1483296739 @default.
• W1967252020 cites W1964935926 @default.
• W1967252020 cites W1969909529 @default.
• W1967252020 cites W1975044185 @default.
• W1967252020 cites W1976657893 @default.
• W1967252020 cites W1982351864 @default.
• W1967252020 cites W1988705311 @default.
• W1967252020 cites W1991957164 @default.
• W1967252020 cites W1997608175 @default.
• W1967252020 cites W2012284731 @default.
• W1967252020 cites W2016736819 @default.
• W1967252020 cites W2018696588 @default.
• W1967252020 cites W2042944249 @default.
• W1967252020 cites W2051572229 @default.
• W1967252020 cites W2054945072 @default.
• W1967252020 cites W2059849177 @default.
• W1967252020 cites W2060616677 @default.
• W1967252020 cites W2064758793 @default.
• W1967252020 cites W2069462575 @default.
• W1967252020 cites W2085527851 @default.
• W1967252020 cites W2086521383 @default.
• W1967252020 cites W2091879794 @default.
• W1967252020 cites W2094161521 @default.
• W1967252020 cites W2100222462 @default.
• W1967252020 cites W2114626700 @default.
• W1967252020 cites W2119986866 @default.
• W1967252020 cites W2121435005 @default.
• W1967252020 cites W2131398804 @default.
• W1967252020 cites W2150039325 @default.
• W1967252020 cites W2169067202 @default.
• W1967252020 doi "https://doi.org/10.1016/j.curtheres.2003.09.008" @default.
• W1967252020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4053047" @default.
• W1967252020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24944407" @default.
• W1967252020 hasPublicationYear "2003" @default.
• W1967252020 type Work @default.
• W1967252020 sameAs 1967252020 @default.
• W1967252020 citedByCount "9" @default.
• W1967252020 countsByYear W19672520202014 @default.
• W1967252020 countsByYear W19672520202015 @default.
• W1967252020 countsByYear W19672520202017 @default.
• W1967252020 countsByYear W19672520202021 @default.
• W1967252020 crossrefType "journal-article" @default.
• W1967252020 hasAuthorship W1967252020A5020939794 @default.
• W1967252020 hasAuthorship W1967252020A5037180436 @default.
• W1967252020 hasBestOaLocation W19672520202 @default.
• W1967252020 hasConcept C126322002 @default.
• W1967252020 hasConcept C159654299 @default.
• W1967252020 hasConcept C168563851 @default.
• W1967252020 hasConcept C174802600 @default.
• W1967252020 hasConcept C187212893 @default.
• W1967252020 hasConcept C188816634 @default.
• W1967252020 hasConcept C197934379 @default.
• W1967252020 hasConcept C203014093 @default.
• W1967252020 hasConcept C2776012195 @default.
• W1967252020 hasConcept C2776194381 @default.
• W1967252020 hasConcept C2777910003 @default.
• W1967252020 hasConcept C2778375690 @default.
• W1967252020 hasConcept C501593827 @default.
• W1967252020 hasConcept C534529494 @default.
• W1967252020 hasConcept C71924100 @default.
• W1967252020 hasConcept C86803240 @default.
• W1967252020 hasConcept C89423630 @default.
• W1967252020 hasConcept C90924648 @default.
• W1967252020 hasConceptScore W1967252020C126322002 @default.
• W1967252020 hasConceptScore W1967252020C159654299 @default.
• W1967252020 hasConceptScore W1967252020C168563851 @default.
• W1967252020 hasConceptScore W1967252020C174802600 @default.
• W1967252020 hasConceptScore W1967252020C187212893 @default.
• W1967252020 hasConceptScore W1967252020C188816634 @default.
• W1967252020 hasConceptScore W1967252020C197934379 @default.
• W1967252020 hasConceptScore W1967252020C203014093 @default.
• W1967252020 hasConceptScore W1967252020C2776012195 @default.
• W1967252020 hasConceptScore W1967252020C2776194381 @default.
• W1967252020 hasConceptScore W1967252020C2777910003 @default.
• W1967252020 hasConceptScore W1967252020C2778375690 @default.
• W1967252020 hasConceptScore W1967252020C501593827 @default.
• W1967252020 hasConceptScore W1967252020C534529494 @default.
• W1967252020 hasConceptScore W1967252020C71924100 @default.
• W1967252020 hasConceptScore W1967252020C86803240 @default.
• W1967252020 hasConceptScore W1967252020C89423630 @default.
• W1967252020 hasConceptScore W1967252020C90924648 @default.
• W1967252020 hasIssue "8" @default.
• W1967252020 hasLocation W19672520201 @default.
• W1967252020 hasLocation W19672520202 @default.
• W1967252020 hasLocation W19672520203 @default.
• W1967252020 hasLocation W19672520204 @default.
• W1967252020 hasOpenAccess W1967252020 @default.
• W1967252020 hasPrimaryLocation W19672520201 @default.
• W1967252020 hasRelatedWork W1511067427 @default.
• W1967252020 hasRelatedWork W1549155385 @default.
• W1967252020 hasRelatedWork W2009011029 @default.

• next